Group 1 - The company, Zhengli New Energy (03677), announced a placement agreement with an exclusive placing agent to sell 45.921 million new H-shares at a price of HKD 10.98 per share, representing approximately 3.19% of the issued H-shares as of the announcement date [1] - The placement price of HKD 10.98 per share is at a discount of about 7.89% compared to the closing price of HKD 11.92 on the trading day before the agreement [1] - If all shares are fully subscribed, the total proceeds from the placement will amount to HKD 504 million, with a net amount estimated at HKD 500.4 million, resulting in a net issue price of approximately HKD 10.90 per share [1] Group 2 - The net proceeds from the placement will enhance the company's financial strength, market competitiveness, and overall capabilities, promoting long-term sustainable development [2] - Approximately 70% of the net proceeds will be allocated to support the construction, equipment purchase, and contingency costs related to the second phase of the new production facility in Changshu [2] - About 10% of the net proceeds will be used for the construction of a pilot line for all-solid-state batteries, another 10% for research and development activities, and the remaining 10% for working capital and general corporate purposes [2]

Group 1 - The company, Zhonglian Development Holdings (00264), has announced a placement agreement to issue up to 15 million shares at a price of HKD 1.75 per share, which represents a discount of approximately 16.27% compared to the closing price of HKD 2.09 on September 30, 2025 [1][2] - The maximum number of shares to be placed corresponds to about 3.25% of the enlarged issued share capital of the company, assuming no changes in the issued share capital during the placement period [1] - The expected net proceeds from the placement, after deducting commissions and related expenses, will be approximately HKD 25.55 million, with a net issue price of about HKD 1.70 per share [2] Group 2 - The company plans to use the net proceeds from the placement for general working capital and to enhance its financial position, with allocations including approximately HKD 6.06 million for materials and equipment related to leather manufacturing and cleaning services, HKD 13.69 million for general operational expenses, HKD 2.94 million for settling outstanding payables, and approximately HKD 2.86 million for new business development opportunities [2]

Group 1 - The company announced a placement agreement with joint placement agents to sell 583,860 shares at a price of HKD 137.00 per share, representing a discount of approximately 14.21% to the closing price on September 25, 2025 [1] - The estimated net proceeds from the placement are approximately HKD 78.3 million, assuming all shares are fully placed and settled [1] - The intended use of the proceeds includes approximately 50% for repaying outstanding bank loans and lease liabilities to optimize the company's financial structure, and the remaining 50% for general corporate purposes [1]

Group 1 - The company, Youbao Online, has entered into a placement agreement to issue up to 157.5 million shares at a price of HKD 2.45 per share to at least six institutional professional investors [1] - The shares to be placed represent approximately 19.96% of the issued H shares as of the announcement date and about 18.94% of the total issued shares [1] - The total expected fundraising amount is approximately HKD 386 million, with a net amount of about HKD 383 million [1] Group 2 - The net proceeds from the fundraising will be allocated as follows: 20% for product development, 20% for offline channel expansion, 30% for the purchase of fixed assets (such as vending machines), and 30% for working capital and general corporate purposes [1] - The company's board believes that this placement will enhance the group's financial position, expand the shareholder base, optimize the capital structure, and support sustainable development [1]

Core Viewpoint - The company, Youbao Online (02429.HK), has entered into a placement agreement to issue up to 157.5 million shares at a price of HKD 2.45 per share, representing a discount of approximately 16.95% from the closing price of HKD 2.95 on September 19, 2025 [1] Group 1 - The placement shares represent about 19.96% of the issued H shares and approximately 18.94% of the total issued shares as of the announcement date [1] - If all placement shares are fully subscribed, the total proceeds from the placement are expected to be approximately HKD 386 million, with a net amount of about HKD 383 million [2] - The net placement price is estimated to be around HKD 2.43 per share [2] Group 2 - Approximately 20% of the net proceeds will be used for developing proprietary intellectual property-based products [2] - Another 20% of the net proceeds will support the offline sales channel expansion for these products [2] - About 30% of the net proceeds will be allocated for acquiring fixed assets, including vending machines for anticipated sales of proprietary products [2] - The remaining 30% will be used for working capital and other general corporate purposes [2] Group 3 - The board believes that the placement will enhance the group's liquidity and financial position, expand the shareholder base, optimize the capital structure, and support the company's healthy and sustainable development [2]

Core Viewpoint - The company, Youbao Online (02429), has entered into a placement agreement to issue up to 157.5 million shares at a price of HKD 2.45 per share, representing a discount of approximately 16.95% from the closing price of HKD 2.95 on September 19, 2025 [1] Group 1 - The placement shares represent approximately 19.96% of the issued H shares and about 18.94% of the total issued shares as of the announcement date [1] - If all placement shares are fully subscribed, the total proceeds from the placement are expected to be approximately HKD 386 million, with a net amount of about HKD 383 million [2] - The net placement price is estimated to be around HKD 2.43 per share [2] Group 2 - Approximately 20.0% of the net proceeds will be used for the development of proprietary intellectual property-based products [2] - Another 20.0% will support the expansion of offline sales channels for these proprietary products [2] - About 30.0% of the net proceeds will be allocated for the acquisition of fixed assets, including vending machines for anticipated sales of proprietary products [2] - The remaining 30.0% will be used for working capital and other general corporate purposes [2] Group 3 - The board believes that the placement will enhance the group's liquidity and financial position, expand the shareholder base, optimize the capital structure, and support the company's healthy and sustainable development [2]

Group 1 - The company, Youbao Online (02429), has entered into a placement agreement with a placement agent to issue up to 157.5 million shares at a price of HKD 2.45 per share, which represents a discount of approximately 16.95% compared to the closing price of HKD 2.95 on September 19, 2025 [1] - The placement shares represent about 19.96% of the issued H shares and approximately 18.94% of the total issued shares as of the announcement date, and about 16.64% and 15.93% of the total issued H shares and shares, respectively, after the placement [1] Group 2 - If all placement shares are fully subscribed, the total proceeds from the placement are expected to be approximately HKD 386 million, with a net amount of about HKD 383 million [2] - The net proceeds will be allocated as follows: approximately 20% for developing proprietary intellectual property-based products, 20% for supporting offline sales channel expansion, 30% for acquiring fixed assets including vending machines, and 30% for working capital and other general corporate purposes [2] - The board believes that the placement will enhance the company's liquidity and financial position, expand the shareholder base, optimize the capital structure, and support the company's healthy and sustainable development [2]

Core Viewpoint - Kingstone Holdings Group (01943) announced a placement agreement with a placement agent to issue up to 150 million shares at a price of HKD 0.617 per share, representing a discount of approximately 19.87% from the closing price of HKD 0.77 on the date of the agreement [1] Group 1 - The placement shares represent approximately 13.04% of the enlarged issued share capital of the company [1] - If all placement shares are fully placed, the total gross proceeds and net proceeds (after deducting placement commission and other expenses) will be approximately HKD 92.55 million and HKD 91.02 million, respectively, equating to a net placement price of about HKD 0.607 per share [1] - The company plans to use approximately HKD 67 million (about 73.61% of the net proceeds) for the development of user-side industrial and commercial energy storage projects and upgrading new industrial parks [1] Group 2 - Approximately HKD 24.02 million (about 26.39% of the net proceeds) will be allocated for general working capital, including repayment of shareholder loans and payment of expenses, salaries and benefits, professional fees, rent, management fees, and other costs [1]

Core Viewpoint - The company, Gilead Sciences, announced a placement and subscription agreement for the sale of 52,400,000 shares at a price of HKD 16.45 per share, representing a discount of approximately 9.9% from the last closing price of HKD 18.26 on August 18 [1] Group 1 - The net proceeds from the subscription are expected to be approximately HKD 467.69 million after deducting commissions and estimated expenses [1] - Approximately 90% of the net proceeds is intended for the clinical trial development of subcutaneous and oral peptide candidates related to obesity [1] - About 10% of the net proceeds is suggested to be used for working capital and other general corporate purposes [1]

Core Viewpoint - The company, 精优药业, has entered into subscription agreements with three parties to issue new shares at a price of HKD 0.097 per share, which represents a discount to the market price on the date of the agreements [1][2][3] Group 1: Subscription Agreements - The company has signed Subscription Agreement I with subscriber I (曾广钊) to issue 30 million shares, representing approximately 1.26% of the existing issued share capital [1] - Subscription Agreement II was signed with subscriber II (张晓佳) for 20 million shares, equivalent to about 0.84% of the existing issued share capital [1] - Subscription Agreement III was established with subscriber III (Fudan Health International Ltd.) for 110 million shares, accounting for approximately 4.6% of the existing issued share capital [2] Group 2: Financial Implications - If all shares from Subscription Agreement I are successfully issued, the total proceeds will be approximately HKD 2.91 million, with a net amount of about HKD 2.89 million [3] - For Subscription Agreement II, the total proceeds are expected to be around HKD 1.94 million, with a net amount of approximately HKD 1.93 million [3] - The proceeds from Subscription Agreement III are projected to total about HKD 10.67 million, with a net amount of approximately HKD 10.60 million [3] Group 3: Use of Proceeds - The net proceeds from the subscriptions will be utilized for potential new business development in health products, equipment, and technology trade, manufacturing, sales, and distribution in China [3] - The company aims to expand its health-related business opportunities into overseas markets while continuing to maintain and develop its existing pharmaceutical business through internal cash resources [3]